Oncologists Accepting Blue Cross and Blue Shield of Massachusetts in Boston, MAPage 4

David Kwiatkowski, MD

Professor of Medicine at Harvard Medical School, and Senior Physician at Brigham and Women’s Hospital/Dana-Farber Cancer Institute. He earned a BSc from Caltec; Senior Physician

Oncology

Jeffrey Clark, MD

Associate Professor, Medicine, Harvard Medical School

Oncology

Lecia Sequist, MD

Associate Professor of Medicine, Harvard Medical School; Mary B. Saltonstall Endowed Chair in Oncology, Massachusetts General Hospital Cancer Center

Oncology

Alicia Morgans, MD

Director of the Survivorship Program at Dana-Farber Cancer Institute. A clinician and investigator, she has expertise in clinical trials and patient-reported; Director, Survivorship Program

Oncology

Frank Hodi, MD

Professor of Medicine, Harvard Medical School; Director, Melanoma Center and Center for Immuno-Oncology, Dana-Farber Brigham Cancer Center

Oncology

Craig Bunnell, MD

Chief Medical Officer of the Dana-Farber Cancer Institute, an NCI-designated Comprehensive Cancer Center and Harvard Medical School-affiliated teaching hos; Associate Professor of Medicine at Harvard Medical School. He has been the principal investigator of several institutional and multicenter clinical trials and serves on

Oncology

Justine Cohen, DO

Senior Physician; Assistant Professor of Medicine, Harvard Medical School

Oncology

Haeseong Park, MD

Medical Oncology

Oncology

Lakshmi Nayak, M.D.

Director of the Center for CNS Lymphoma at Dana-Farber Cancer Institute in Boston. She is an Associate Professor of Neurology at Harvard Medical School. She r; Director of the Center for Central Nervous System (CNS) Lymphoma

Oncology

Omar Nadeem, M.D.

Senior Physician, Assistant Professor of Medicine at Harvard Medical School

Oncology

Ephraim Hochberg, MD

Oncology

Richard Penson, MD

Associate Professor of Medicine, Harvard Medical School; Clinical Director, Medical Gynecologic Oncology, Massachusetts General Hospital

Oncology

Elad Sharon, M.D.

Director of the Immunotherapy Toxicity Program and a Member of the Faculty of Medicine at Harvard Medical School. From 2011 through August 2023, Dr. Sha

Oncology

Wenxin Xu, M.D.

Instructor in Medicine, Genitourinary Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute

Oncology

Leah Biller, MD

Assistant Professor of Medicine at Harvard Medical School and a physician in the Gastrointestinal Cancer Center and the Cancer Genetics and Prevention Center at Dana-Far

Oncology

Paul Mathew, M.D.

Associate Professor, Medical Oncology, Tufts University School of Medicine

Oncology

Ross Berkowitz, MD

Professor of Gynecology, Harvard Medical School

Oncology

Kent Mouw, M.D., PH.D.

Director, Bladder Cancer Center; Assistant Professor of Radiation Oncology, Harvard Medical School

Oncology

Caroline Block, MD

Chief of Hematology and Medical Oncology, Medical Director of the Breast Clinic, Director of Oncology Clinical Research and Director of the Anticoagulation; Director

Oncology

Atul Shinagare, M.D.

Chair, Clinical Operations, Division of Oncoradiology, Brigham Health; Chief of Abdominal Imaging, Brigham Health

Oncology